Document is current
Any future updates will be listed below
-
Authors
Bonneau, Claire
Eliès, Antoine
Kieffer, Yann
Bourachot, Brigitte
Ladoire, Sylvain
Pelon, Floriane
Hequet, Delphine
Guinebretière, Jean-Marc
Blanchet, Christophe
Vincent-Salomon, Anne
Rouzier, Roman
Mechta-Grigoriou, Fatima https://orcid.org/0000-0002-3751-6989
-
Funding
Funding for this research was provided by:
Institut National du Cancer (9963)
Ligue Nationale Contre le Cancer (Labelisation)
Institut Curie (PIC)
- License Information
-
More Information
Article History
Received: 3 January 2020
Accepted: 30 June 2020
First Online: 14 July 2020
Ethics approval and consent to participate
: All patients included in our study and treated at IC were informed by their referring oncologist that their biological samples could be used for research purposes. All patients signed informed consent of non-opposition for the collection of excessive tumor samples and molecular analysis.
: All authors have given consent for publication.
: F.M-G. received research support from Innate-Pharma, Roche and Bristol-Myers-Squibb (BMS). R. R received financial support for research (travel reimbursement) and speaker honoraria from Nanostring Technologies. Other authors declare no potential conflict of interest.
